This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Mar. 22, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!



Stanford gene researchers see diabetes develop
San Francisco Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stanford researchers have unveiled the most detailed biological profile of a human being done so far: a peek at one man's genetic foundation, with snapshots of the millions of proteins and molecules in constant flux in his body. The research provides some proof that detailed genetic profiling could be used not just to predict an individual's chances of developing disease, but also to identify the smallest molecular changes that show when a person starts to become ill, personalized medicine experts said. More

Genetic research could aid regenerative treatment
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Research from a Kansas State University professor may make it easier to recover after spinal cord injury or to study neurological disorders. He is researching genetic models for spinal cord injury or diseases such as Parkinson's disease. He is developing technology that can advance cellular therapy and regenerative medicine. More

New drug a breakthrough for cystic fibrosis patients
The Seattle Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new drug, Kalydeco, is the first medication that targets the genetic cause of cystic fibrosis, not just its symptoms. Although it is effective only for a small number of patients, the drug is hailed as an important breakthrough. More

 Biotech/Diagnostics/Personalized Medicine

Court throws out Prometheus drug patent
The Associated Press via Yahoo News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories for a test that could help doctors set drug doses for autoimmune diseases like Crohn's disease, a decision that could affect the burgeoning field of personalized medicine. The justices unanimously agreed the patents held by the company were invalid because they were based on the laws of nature, which are unpatentable. More

Guidelines focus on newly diagnosed HIV patients
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Worried that too few people with HIV receive the care they need, infectious diseases experts have issued guidelines calling on physicians to ensure newly diagnosed patients start treatment and adhere to life-long drug regimens. The guidelines recommend after an initial visit for treatment programs, nurses or other staff members periodically call patients to ensure that they are properly taking their medications. More

Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

To fix a heart, doctors train girl's body to grow new part
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have long been captivated by the ability of animals such as salamanders and starfish to regrow body parts lost to injury. It was long assumed that developmental forces that create a human being in the womb are lost at birth. But recent advances in stem-cell research and tissue engineering suggest that regenerative forces can be reawakened with strategically implanted stem cells and other tissue. More

True bionic limb remains far out of reach
Wired    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Prosthetics give their "best guess" in reacting to commands, one expert says. The problem bedevils all of the current research in prosthetics. Today's computer-controlled prosthetic arms can carry out only a few commands. A decade ago, researchers seemed on the cusp of creating a working interface between body and machine. More

 Emerging Medical Technologies

Building a better inhaler
The Atlantic    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefAsthma inhalers seem easy to use, but they require a good deal of precision during shaking, inhalation and pressing of the button. Cambridge Consultants has developed a practice inhaler, called T-Haler, that can correct improper usage. The device senses whether it received enough shaking, how much inhalation pressure was applied and whether the button was pressed at the right time to release the medication. More

Researchers print live cells with inkjet printer
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from Clemson University in South Carolina have found a way to create temporary holes in the membranes of live cells using a standard inkjet printer. The method will be published in the Journal of Visualized Experiments. Researchers have been using the method to print cells onto slides, but that they have only recently discovered that printing the cells causes the disruption in their membranes for a few hours. More

 Managed Healthcare News

Some 'uninsurables' face extra hurdle in covering preexisting ailments
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The "uninsurables" — people with serious medical conditions who can't buy private health coverage — are supposed to have a safety net to rely on in the new preexisting condition insurance plans. These comprehensive plans, created by the federal healthcare law, take all comers who have been uninsured for at least six months. More

CFO: Aetna ready for 'dual eligibles' despite commercial focus
The Wall Street Journal (subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aetna believes it can ably serve health-challenged patients covered by both Medicare and Medicaid, even though the company doesn't have a major stake in those markets. Some of Aetna's big competitors have recently made deals with an eye on dual patients, and Aetna has faced questions about whether it has the right makeup for the market. More

 FDA: New Treatments and Technology

FDA to hold hearing on whether people can self-scan for scripts
KPCC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefThe Food and Drug Administration is preparing to hold hearings on whether consumers should be able to use new technologies to self-screen for some medications that now require a doctor's visit and a prescription. The drugs under consideration are limited to common treatments for asthma, diabetes, high blood pressure, high cholesterol and migraine headaches. More

AstraZeneca gives up antidepressant
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AstraZeneca has thrown in the towel on an experimental antidepressant targeting nicotine receptors after the drug licensed from Targacept failed in two remaining clinical trials, thinning out its pipeline further. While the news had been widely expected, since two previous Phase III studies also missed their targets, it hit shares in Targacept hard. More

"Between 2001 and 2009, the number of people diagnosed with asthma grew by 4.3 million, according to the Centers for Disease Control and Prevention."
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to %%emailaddr%%. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 15, 2012
March 8, 2012
March 1, 2012
Feb. 23, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063